HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Supplemental figure Supplemental table Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McMonagle, P. Articles by Hutchinson, M. Search for Related Content PubMed PubMed Citation Articles by McMonagle, P. Articles by Hutchinson, M.

Phenotype of AD-HSP due to mutations in the SPAST gene

Comparison with AD-HSP without mutations

From the Department of Neurology (Drs. McMonagle, Webb, and Hutchinson), St. Vincent’s University Hospital and Department of Pathology (Drs. Byrne and Parfrey, B. Fitzgerald), University College Dublin and St. Vincent’s University Hospital, Dublin, Ireland.

Address correspondence and reprint requests to Dr. P. McMonagle, Department of Neurology, St. Vincent’s University Hospital, Elm Park, Dublin 4, Ireland; e-mail: p.mcmonagle{at}st-vincents.ie

BACKGROUND: "Pure" autosomal dominant hereditary spastic paraparesis (AD-HSP) is clinically and genetically heterogeneous. There are at least seven genetic loci with varying ages at onset and disability. The SPAST gene at the SPG4 locus on chromosome 2p is the major disease gene for AD-HSP.

OBJECTIVES: To investigate whether there are distinct clinical features among families with AD-HSP due to SPAST mutations compared with families excluded from SPG4.

METHODS: Nineteen families with "pure" AD-HSP were identified, and the clinical features of family members were compared using a standard protocol. With use of genetic studies, the families were divided into two groups for comparison: those with mutations in SPAST, the "mutation-positive" group, and those excluded from SPG4 on the basis of linkage studies, the "SPG4-excluded" group.

RESULTS: Twenty-nine individuals from four families had mutations in SPAST, whereas 22 individuals from three families comprised the SPG4-excluded group; in 11 families, the pattern of linkage was unknown. In the one remaining family, no mutations were found despite strong linkage to SPG4. Different mutations were identified in the four SPAST pedigrees, but the clinical picture was similar in each. Comparison of the mutation-positive group with the SPG4-excluded group revealed an older age at onset (p = 0.03), more disability (p = 0.001), more rapidly progressive paraparesis (p = 0.044), and more cognitive impairment (p = 0.024) among affected individuals with SPAST mutations, not confounded by disease duration. Conclusion: Despite different mutations, SPAST families have a similar phenotype that can be distinguished from other genetic groups.

This article has been cited by other articles:

				S. Murphy, G. Gorman, C. Beetz, P. Byrne, M. Dytko, P. McMonagle, K. Kinsella SRN, M. Farrell, and M. Hutchinson Dementia in SPG4 hereditary spastic paraplegia: Clinical, genetic, and neuropathologic evidence Neurology, August 4, 2009; 73(5): 378 - 384. [Abstract] [Full Text] [PDF]

				C. Beetz, A.O.H. Nygren, J. Schickel, M. Auer-Grumbach, K. Burk, G. Heide, J. Kassubek, S. Klimpe, T. Klopstock, F. Kreuz, et al. High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia Neurology, December 12, 2006; 67(11): 1926 - 1930. [Abstract] [Full Text] [PDF]

				S.-Y. Park, C.-S. Ki, H.-J. Kim, J.-W. Kim, D. H. Sung, B. J. Kim, and W. Y. Lee Mutation Analysis of SPG4 and SPG3A Genes and Its Implication in Molecular Diagnosis of Korean Patients With Hereditary Spastic Paraplegia Arch Neurol, July 1, 2005; 62(7): 1118 - 1121. [Abstract] [Full Text] [PDF]

				P. F. Chinnery, S. M. Keers, M. J. Holden, V. Ramesh, and A. Dalton Infantile hereditary spastic paraparesis due to codominant mutations in the spastin gene Neurology, August 24, 2004; 63(4): 710 - 712. [Abstract] [Full Text] [PDF]

				P. McMonagle, P. Byrne, and M. Hutchinson Further evidence of dementia in SPG4-linked autosomal dominant hereditary spastic paraplegia Neurology, February 10, 2004; 62(3): 407 - 410. [Abstract] [Full Text] [PDF]

				C. M. E. Tallaksen, E. Guichart-Gomez, P. Verpillat, V. Hahn-Barma, M. Ruberg, B. Fontaine, A. Brice, B. Dubois, and A. Durr Subtle Cognitive Impairment but No Dementia in Patients With Spastin Mutations Arch Neurol, August 1, 2003; 60(8): 1113 - 1118. [Abstract] [Full Text] [PDF]

				I Yabe, H Sasaki, K Tashiro, T Matsuura, T Takegami, and T Satoh Spastin gene mutation in Japanese with hereditary spastic paraplegia J. Med. Genet., August 1, 2002; 39(8): e46 - 46. [Full Text] [PDF]

				P McMonagle, S Webb, and M Hutchinson The prevalence of "pure" autosomal dominant hereditary spastic paraparesis in the island of Ireland J. Neurol. Neurosurg. Psychiatry, January 1, 2002; 72(1): 43 - 46. [Abstract] [Full Text] [PDF]